Elena E. Takeuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena E. Takeuchi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ada Keding
Department of Health Sciences, University of York, York, UK
1 shared publication - David Feeny
McMaster University, Hamilton, Canada
1 shared publication Dawn L. Alison
Consultant in Medical Oncology and Palliative Medicine same unit as SPR St James's University Hospital Beckett Street Leeds West Yorkshire LS9 7TF UK
1 shared publicationGalina Velikova
Elena E. Takeuchi, Ada Keding, Noha Awad, Lyndsay J. Campbell, and Galina Velikova, St James's Institute of Oncology; Peter J. Selby, Leeds Institute of Molecular Medicine; Julia M. Brown, Clinical Trials Research Unit, University of Leeds, Leeds; and Ursula Hofmann, Huddersfield Royal Infirmary, Huddersfield, United Kingdom
1 shared publication- Galina Velikova
Patient Centred Outcomes Research, Leeds Institute of Medical Research, University of Leeds, Leeds, UK
1 shared publication Julia M. Brown
Elena E. Takeuchi, Ada Keding, Noha Awad, Lyndsay J. Campbell, and Galina Velikova, St James's Institute of Oncology; Peter J. Selby, Leeds Institute of Molecular Medicine; Julia M. Brown, Clinical Trials Research Unit, University of Leeds, Leeds; and Ursula Hofmann, Huddersfield Royal Infirmary, Huddersfield, United Kingdom
1 shared publication
Latest Publications
- 15 January 2015
- Published by Springer Nature in Quality of Life Research
- Vol. 24 (7) , 1707-1718
Training clinicians in how to use patient-reported outcome measures in routine clinical practice
Introduction Patient-reported outcome measures (PROs) were originally developed for comparing groups of people in clinical trials and population studies, and the results were used to support treatment recommendations or inform health policy, but there was not direct benefit for the participants providing PROs data. However, as the experience in using those measures increased, it became obvious the clinical value in using individual patient PROs profiles in daily practice to identify/monitor symptoms, evaluate treatment outcomes and support shared decision-making. A key issue limiting successful implementation is clinicians’ lack of knowledge on how to effectively utilize PROs data in their clinical encounters. Methods Using a change management theoretical framework, this paper describes the development and implementation of three programs for training clinicians to effectively use PRO data in routine practice. The training programs are in three diverse clinical areas (adult oncology, lung transplant and paediatrics), in three countries with different healthcare systems, thus providing a rare opportunity to pull out common approaches whilst recognizing specific settings. For each program, we describe the clinical and organizational setting, the program planning and development, the content of the training session with supporting material, subsequent monitoring of PROs use and evidence of adoption. The common successful components and practical steps are identified, leading to discussion and future recommendations. Results The results of the three training programs are described as the implementation. In the oncology program, PRO data have been developed and are currently evaluated; in the lung transplant program, PRO data are used in daily practice and the integration with electronic patient records is under development; and in the paediatric program, PRO data are fully implemented with around 7,600 consultations since the start of the implementation. Conclusion Adult learning programs teaching clinicians how to use and act on PROs in clinical practice are a key steps in supporting patient engagement and participation in shared decision-making. Researchers and clinicians from different clinical areas should collaborate to share ideas, develop guidelines and promote good practice in patient-centred care.
- 15 January 2015
- Published by Springer Nature in Quality of Life Research
- Vol. 24 (7) , 1707-1718
Training clinicians in how to use patient-reported outcome measures in routine clinical practice
Introduction Patient-reported outcome measures (PROs) were originally developed for comparing groups of people in clinical trials and population studies, and the results were used to support treatment recommendations or inform health policy, but there was not direct benefit for the participants providing PROs data. However, as the experience in using those measures increased, it became obvious the clinical value in using individual patient PROs profiles in daily practice to identify/monitor symptoms, evaluate treatment outcomes and support shared decision-making. A key issue limiting successful implementation is clinicians’ lack of knowledge on how to effectively utilize PROs data in their clinical encounters. Methods Using a change management theoretical framework, this paper describes the development and implementation of three programs for training clinicians to effectively use PRO data in routine practice. The training programs are in three diverse clinical areas (adult oncology, lung transplant and paediatrics), in three countries with different healthcare systems, thus providing a rare opportunity to pull out common approaches whilst recognizing specific settings. For each program, we describe the clinical and organizational setting, the program planning and development, the content of the training session with supporting material, subsequent monitoring of PROs use and evidence of adoption. The common successful components and practical steps are identified, leading to discussion and future recommendations. Results The results of the three training programs are described as the implementation. In the oncology program, PRO data have been developed and are currently evaluated; in the lung transplant program, PRO data are used in daily practice and the integration with electronic patient records is under development; and in the paediatric program, PRO data are fully implemented with around 7,600 consultations since the start of the implementation. Conclusion Adult learning programs teaching clinicians how to use and act on PROs in clinical practice are a key steps in supporting patient engagement and participation in shared decision-making. Researchers and clinicians from different clinical areas should collaborate to share ideas, develop guidelines and promote good practice in patient-centred care.
- 20 July 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (21) , 2910-2917
Impact of Patient-Reported Outcomes in Oncology: A Longitudinal Analysis of Patient-Physician Communication
Purpose: Regularly collecting patient-reported outcomes (PROs) of health-related quality of life with feedback to oncologists may assist in eliciting and monitoring patients' problems during cancer treatment. This study examined how PRO feedback had an impact on patient-physician communication over time to gain a better understanding of how it may influence patient care. Patients and Methods: Exploratory analyses were performed on a data set from a previous study. Patients were randomly assigned to intervention (regular completion of European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 and Hospital Anxiety and Depression Scale with feedback to oncologists), attention-control (completion of same questionnaires without feedback), and control (standard care) arms. The content of consultation audio recordings between 28 oncologists and 198 patients over four consecutive visits (792 consultations) was analyzed. Mixed-effects models and multivariate regressions were used to examine the longitudinal impact of the intervention on patient-physician communication, dynamics of patient-physician interaction, and the association between PROs and the content of clinic discussion. Results: Patients in the intervention arm discussed more symptoms over time compared with patients in the attention-control (P = .008) and control (P = .04) arms. No study arm effect was observed for function discussions. Discussion topics were predominantly raised by patients/relatives, regardless of arm allocation. Clinic discussions were associated with severity of patient-reported symptoms but not with patient-reported functional concerns. Conclusion: A positive longitudinal impact of the intervention on symptom discussion was observed, but not for function discussion, suggesting that potentially serious problems may remain unaddressed. Training oncologists in responding to patient-reported functional concerns may increase the impact of this intervention.
- 20 July 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (21) , 2910-2917
Impact of Patient-Reported Outcomes in Oncology: A Longitudinal Analysis of Patient-Physician Communication
Purpose: Regularly collecting patient-reported outcomes (PROs) of health-related quality of life with feedback to oncologists may assist in eliciting and monitoring patients' problems during cancer treatment. This study examined how PRO feedback had an impact on patient-physician communication over time to gain a better understanding of how it may influence patient care. Patients and Methods: Exploratory analyses were performed on a data set from a previous study. Patients were randomly assigned to intervention (regular completion of European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 and Hospital Anxiety and Depression Scale with feedback to oncologists), attention-control (completion of same questionnaires without feedback), and control (standard care) arms. The content of consultation audio recordings between 28 oncologists and 198 patients over four consecutive visits (792 consultations) was analyzed. Mixed-effects models and multivariate regressions were used to examine the longitudinal impact of the intervention on patient-physician communication, dynamics of patient-physician interaction, and the association between PROs and the content of clinic discussion. Results: Patients in the intervention arm discussed more symptoms over time compared with patients in the attention-control (P = .008) and control (P = .04) arms. No study arm effect was observed for function discussions. Discussion topics were predominantly raised by patients/relatives, regardless of arm allocation. Clinic discussions were associated with severity of patient-reported symptoms but not with patient-reported functional concerns. Conclusion: A positive longitudinal impact of the intervention on symptom discussion was observed, but not for function discussion, suggesting that potentially serious problems may remain unaddressed. Training oncologists in responding to patient-reported functional concerns may increase the impact of this intervention.
- Open Access
- 1 February 2008
- Published by Elsevier in Continuing Education in Anaesthesia Critical Care & Pain
- Vol. 8 (1) , 36-38
What’s new in oncology: targeted therapy
The ‘magic bullet’ concept of Paul Ehrlich that ‘toxins’ could be targeted to cancer took a leap forward when the hybridoma technique was described by Kohler and Milstein1 in 1975 allowing unlimited production of monoclonal antibodies (MAbs). However, the therapeutic promise of MAbs has taken some time to be realized requiring humanization of mouse antibodies, recombinant production protocols, and discovery of ideal targets.
- 1 February 2008
- Published by Elsevier in Continuing Education in Anaesthesia Critical Care & Pain
- Vol. 8 (1) , 36-38
Open AccessWhat’s new in oncology: targeted therapy
The ‘magic bullet’ concept of Paul Ehrlich that ‘toxins’ could be targeted to cancer took a leap forward when the hybridoma technique was described by Kohler and Milstein1 in 1975 allowing unlimited production of monoclonal antibodies (MAbs). However, the therapeutic promise of MAbs has taken some time to be realized requiring humanization of mouse antibodies, recombinant production protocols, and discovery of ideal targets.